ES2157523T3 - Solucion de dialisis peritoneal. - Google Patents

Solucion de dialisis peritoneal.

Info

Publication number
ES2157523T3
ES2157523T3 ES97203411T ES97203411T ES2157523T3 ES 2157523 T3 ES2157523 T3 ES 2157523T3 ES 97203411 T ES97203411 T ES 97203411T ES 97203411 T ES97203411 T ES 97203411T ES 2157523 T3 ES2157523 T3 ES 2157523T3
Authority
ES
Spain
Prior art keywords
peritoneal dialysis
dialysis solution
polypeptides
dectrose
synthetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97203411T
Other languages
English (en)
Inventor
Leo Martis
Dirk Faict
Ron Burke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter International Inc
Original Assignee
Baxter International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25541397&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2157523(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Baxter International Inc filed Critical Baxter International Inc
Application granted granted Critical
Publication of ES2157523T3 publication Critical patent/ES2157523T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A61M1/287—Dialysates therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • External Artificial Organs (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA SOLUCION CONTIENE COMO AGENTES OSMOTICOS LA DEXTROSA Y POLIPEPTIDOS. LOS POLIPEPTIDOS SON SINTETICOS Y POSEEN UNA LONGITUD DE 4 A 10 AMINOACIDOS.
ES97203411T 1992-12-22 1993-12-10 Solucion de dialisis peritoneal. Expired - Lifetime ES2157523T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/995,106 US6380163B1 (en) 1992-12-22 1992-12-22 Peritoneal dialysis solutions with polypeptides

Publications (1)

Publication Number Publication Date
ES2157523T3 true ES2157523T3 (es) 2001-08-16

Family

ID=25541397

Family Applications (3)

Application Number Title Priority Date Filing Date
ES97203411T Expired - Lifetime ES2157523T3 (es) 1992-12-22 1993-12-10 Solucion de dialisis peritoneal.
ES94904432T Expired - Lifetime ES2119161T3 (es) 1992-12-22 1993-12-10 Soluciones de dialisis peritoneal mejoradas que incluyen polipeptidos.
ES97203410T Expired - Lifetime ES2180002T3 (es) 1992-12-22 1993-12-10 Soluciones de dialisis peritoneal mejoradas.

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES94904432T Expired - Lifetime ES2119161T3 (es) 1992-12-22 1993-12-10 Soluciones de dialisis peritoneal mejoradas que incluyen polipeptidos.
ES97203410T Expired - Lifetime ES2180002T3 (es) 1992-12-22 1993-12-10 Soluciones de dialisis peritoneal mejoradas.

Country Status (11)

Country Link
US (2) US6380163B1 (es)
EP (3) EP0827749B2 (es)
JP (2) JP3676362B2 (es)
AT (3) ATE168010T1 (es)
AU (1) AU683863B2 (es)
CA (1) CA2129991A1 (es)
DE (3) DE69319583T2 (es)
DK (3) DK0626857T3 (es)
ES (3) ES2157523T3 (es)
SG (3) SG93822A1 (es)
WO (1) WO1994014468A1 (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2750642A1 (es) * 2018-09-26 2020-03-26 Univ Vigo Composición farmacéutica que comprende proteína amiloide P de suero para tratar la insuficiencia renal aguda o crónica

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005531630A (ja) * 2002-07-01 2005-10-20 株式会社ジェイ・エム・エス 腹膜透析液
US20050148647A1 (en) * 2003-10-31 2005-07-07 Landry Donald W. Hemodialysis solutions and uses thereof
US7236975B2 (en) * 2004-04-13 2007-06-26 Bea Systems, Inc. System and method for controlling access to anode in a virtual content repository that integrates a plurality of content repositories
US7935070B2 (en) 2005-01-28 2011-05-03 Fresenius Medical Care North America Systems and methods for dextrose containing peritoneal dialysis (PD) solutions with neutral pH and reduced glucose degradation product
CN101257908B (zh) * 2005-04-20 2010-09-08 株式会社林原生物化学研究所 腹膜透析液
US20100099628A1 (en) 2007-03-02 2010-04-22 Zyto-Protec Gmbh Carbohydrate-based peritoneal dialysis fluid comprising glutamine residue
JP5438751B2 (ja) * 2008-03-20 2014-03-12 バクスター・インターナショナル・インコーポレイテッド 酵素消化による微生物生成物の破壊
JP5498491B2 (ja) 2008-07-07 2014-05-21 ペンテック ヘルス， インコーポレイテッド 栄養組成物およびその栄養組成物の使用方法
WO2011081679A1 (en) 2010-01-04 2011-07-07 Pentec Health, Inc. Nutritive compositions and methods of using same
US9585810B2 (en) 2010-10-14 2017-03-07 Fresenius Medical Care Holdings, Inc. Systems and methods for delivery of peritoneal dialysis (PD) solutions with integrated inter-chamber diffuser
TW201338803A (zh) * 2012-03-23 2013-10-01 zheng-yi Lin 用於治療寵物腎衰竭之醫藥組合物
WO2018165108A1 (en) 2017-03-08 2018-09-13 Hope Medical Enterprises, Inc. Dba Hope Pharmaceuticals Intradialytic use of sodium thiosulfate
KR102647803B1 (ko) 2017-03-08 2024-03-15 호프 메디칼 엔터프라이즈스, 인크, 디비에이, 호프파마수으티칼즈 아질산나트륨의 투석중 용도
EP3766529A4 (en) 2018-03-14 2022-03-23 Beacon Medcare (HK) Limited Composition for purification of biofluids

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4168337A (en) * 1974-07-05 1979-09-18 Societe Europeenne De Propulsion Three dimensional structure for reinforcement
US3939261A (en) * 1974-08-30 1976-02-17 Colgate-Palmolive Company Flavored dentifrice
US4179338A (en) 1977-09-19 1979-12-18 Gordon Maurice R Microbiological medium suitable for sterilization by ionizing radiation
FR2474828B1 (fr) 1980-02-01 1983-09-09 Agronomique Inst Nat Rech Procede de traitement d'une matiere premiere a base de caseine, contenant des phosphocaseinates de cations bivalents, produits obtenus et application
US4309417A (en) 1980-07-10 1982-01-05 Stauffer Chemical Company Protein fortified isotonic beverages
US4339433A (en) † 1981-01-09 1982-07-13 Baxter Travenol Laboratories, Inc. Additives for peritoneal dialysis solutions
JPS58500563A (ja) † 1981-04-27 1983-04-14 バクスタ−、トラベノ−ル、ラボラトリ−ズ、インコ−ポレイテツド グルコ−ス、アミノ酸およびインシユリンを含む透析液
US4574085A (en) † 1981-05-15 1986-03-04 Baxter Travenol Laboratories, Inc. Method for using dialysis solution containing glycerol
US4761237A (en) 1981-07-10 1988-08-02 Baxter Travenol Laboratories, Inc. Peritoneal dialysis solution containing carbohydrate polymers
EP0076355A3 (en) 1981-10-01 1983-05-25 Abbott Laboratories Improved peritoneal dialysis solution
US4448716A (en) * 1982-03-04 1984-05-15 G. D. Searle & Co. Dipeptide sweetener-metal complexes
US4886789A (en) 1983-01-12 1989-12-12 M. L. Laboratories Plc Peritoneal dialysis and compositions for use therein
GB8404299D0 (en) 1984-02-18 1984-03-21 Milner Research Ireland Ltd Peritoneal dialysis
US4604379A (en) 1984-06-18 1986-08-05 Curators Of The University Of Missouri Dialysis solutions containing cross-linked gelatin
US4608043A (en) * 1984-06-22 1986-08-26 Abbott Laboratories I.V. fluid storage and mixing system
DE3428201A1 (de) 1984-07-31 1986-02-06 Laevosan-Gesellschaft mbH & Co. KG, Linz Loesungen fuer die peritonealdialyse
US4614657A (en) * 1984-09-11 1986-09-30 The Quaker Oats Company Dipeptide sweetened ready-to-eat cereal and coating method
US4631211A (en) * 1985-03-25 1986-12-23 Scripps Clinic & Research Foundation Means for sequential solid phase organic synthesis and methods using the same
JPS61247466A (ja) * 1985-04-25 1986-11-04 テルモ株式会社 腹膜透析用透析液
GB8521712D0 (en) 1985-08-31 1985-10-02 Giltech Ltd Solution for peritoneal dialysis
DE3683583D1 (de) * 1985-09-10 1992-03-05 Res Corp Technologies Inc Osmotische mittel fuer peritonealdialyse.
DK589785A (da) 1985-12-18 1987-06-19 Samuelsson Ernst Gunnar Peptidpraeparat, fremgangsmaade til fremstilling deraf samt anvendelse af peptidpraeparatet
CA1311583C (en) * 1986-12-15 1992-12-15 Gerard Armand Marguerie De Rotrou Peptide derivatives and their application, in particular in therapy
GR870129B (en) * 1987-01-27 1987-02-04 Giatzidis Ippokratis Stable bicarbonate - glycylglycine dialysate for hemodialysis and peritoneal dialysis
CH686778A5 (fr) * 1987-05-29 1996-06-28 Vifor Medical Ag Récipient destiné au stockage séparé de composés actifs et à leur mélange subséquent.
DE3801391A1 (de) * 1988-01-19 1989-07-27 Berkefeld Filter Anlagenbau Gm Verfahren zum behandeln einer fluessigkeit, die eiweisse unterschiedlicher art und andere substanzen, wie salze, zucker, mineralbestandteile, fett, vitamine, enzyme und minorbestandteile enthaelt
DE3812525C1 (es) * 1988-04-15 1989-06-22 Fresenius Ag, 6380 Bad Homburg, De
US5010175A (en) * 1988-05-02 1991-04-23 The Regents Of The University Of California General method for producing and selecting peptides with specific properties
US5053393A (en) * 1988-07-20 1991-10-01 Monsanto Company Novel platelet-aggregation inhibitor
US5092838A (en) * 1989-11-30 1992-03-03 Baxter International Inc. Histidine buffered peritoneal dialysis solution
DE3917251A1 (de) * 1989-05-26 1990-11-29 Fresenius Ag Natriumbicarbonat enthaltendes konzentrat sowie verfahren zur herstellung einer dialysierfluessigkeit
DE3940052A1 (de) * 1989-12-04 1991-06-06 Nephro Medica Pharma Dialysier- und spuelloesung zur intraperitonealen verabreichung
US5182366A (en) * 1990-05-15 1993-01-26 Huebner Verena D Controlled synthesis of peptide mixtures using mixed resins
US5192746A (en) * 1990-07-09 1993-03-09 Tanabe Seiyaku Co., Ltd. Cyclic cell adhesion modulation compounds
ATE139451T1 (de) * 1992-04-06 1996-07-15 Baxter Int Wässrige peritonealdialyse-lösung

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2750642A1 (es) * 2018-09-26 2020-03-26 Univ Vigo Composición farmacéutica que comprende proteína amiloide P de suero para tratar la insuficiencia renal aguda o crónica

Also Published As

Publication number Publication date
DE69332106D1 (de) 2002-08-14
DK0626857T3 (da) 1999-04-19
US20010056062A1 (en) 2001-12-27
DK0827748T3 (da) 2002-10-21
SG50379A1 (en) 1998-07-20
WO1994014468A1 (en) 1994-07-07
DK0827749T3 (da) 2001-05-28
AU683863B2 (en) 1997-11-27
DE69330189D1 (de) 2001-06-07
ATE220328T1 (de) 2002-07-15
EP0827748B1 (en) 2002-07-10
JP2005162767A (ja) 2005-06-23
EP0827749B2 (en) 2006-09-27
DE69319583T2 (de) 1999-04-01
DE69330189T2 (de) 2001-08-23
EP0827749A2 (en) 1998-03-11
DE69332106T3 (de) 2007-03-01
ES2180002T3 (es) 2003-02-01
EP0827749B1 (en) 2001-05-02
US6380163B1 (en) 2002-04-30
EP0827748A2 (en) 1998-03-11
SG89264A1 (en) 2002-06-18
ES2119161T3 (es) 1998-10-01
JPH07504351A (ja) 1995-05-18
ATE200866T1 (de) 2001-05-15
JP3676362B2 (ja) 2005-07-27
US6730660B2 (en) 2004-05-04
CA2129991A1 (en) 1994-07-07
DE69332106T2 (de) 2003-02-27
AU5848594A (en) 1994-07-19
DE69319583D1 (de) 1998-08-13
ATE168010T1 (de) 1998-07-15
EP0827748B2 (en) 2006-08-02
EP0827749A3 (en) 1998-04-22
DE69330189T3 (de) 2007-05-03
EP0626857A1 (en) 1994-12-07
SG93822A1 (en) 2003-01-21
EP0626857B1 (en) 1998-07-08
EP0827748A3 (en) 1998-04-22

Similar Documents

Publication Publication Date Title
DK0827749T3 (da) Peritoneal dialysis solution
FI955336A7 (fi) Varjoaineina käytettäviä trisyklopolyatsamakrosyklofosfonihappoja, nii den komplekseja ja johdannaisia
DE69107900D1 (de) Kunststoff-Schnellverbindungskupplung.
FI894095A0 (fi) Vaermare foer anvaendning i mikrovaogsugnar.
FR2651294B1 (fr) Unite d'etancheite.
DE69420744D1 (de) Verdrängungspumpe des membrantyps
DE68906911D1 (de) Ganz trockene tauchmotorpumpe mit zugehoerigem dichtungssystem.
DE68904046D1 (de) Dialysesystem.
DE3689191D1 (de) Gereinigtes protein mit angiogenischer wirkung und dessen herstellung.
DE68911314D1 (de) Schlauch-Klemmvorrichtung.
MX9201416A (es) Peptidos y pseudopeptidos antitromboticos.
FI972384A7 (fi) Uudet dipeptidiset p-amidinobentsyyliamidit, jotka sisältävät N-termin aalisia sulfonyyli- tai amidinosulfonyyliryhmiä
FI880032A7 (fi) Vaetskeringspump i tvao steg.
DE69006530D1 (de) Mit Ventilen versehenes Verzweigungsgehäuse.
DE69309901D1 (de) Aminosäurederivate mit anticholecystokininwirkung
DE69014115D1 (de) Stabilisierte, starke grf-analoga.
FI943218L (fi) Kaseinomakropeptidin peptidit, mainittujen peptidien vasta-aineet ja käytöt
FR2659411B1 (fr) Joint d'etancheite.
DE69534738D1 (de) Leukocyten-aktivierender Faktor
NO881000L (no) Injeksjonsslange.
KR940022928U (ko) 공기주입용 펌프
FI910878A7 (fi) Taetning i maonga delar.
FI912665A0 (fi) Homogen enzym-immunologisk bestaemning.
NO930711D0 (no) Aminosyrederivater ringsluttet i den c-terminale ende
FI945682A0 (fi) Parannuksia havupuiden kasvatuksessa tai havupuiden kasvatukseen liittyen

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 827749

Country of ref document: ES